Listed

Faeth Therapeutics, Inc.

FTHNasdaqCIK 1829802HealthcareFiscal year ends Dec 31

Reports and events: 130 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Faeth Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2022-08-0907:46 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-215634
2022-07-1917:30 ETSC 13DOwnership report, active investor0001193805-22-001110
2022-06-1416:27 ET8-K5.07 Shareholder vote results0001193125-22-173857
2022-05-1017:03 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009054
2022-05-1007:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-145700
2022-04-2816:13 ETDEF 14AProxy statementPeriod 2022-06-100001193125-22-127574
2022-04-2008:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-110334
2022-03-1507:01 ET10-KAnnual reportPeriod 2021-12-310000950170-22-003646
2022-03-1008:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-071338
2022-03-0916:23 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-070592
2022-01-1008:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-005156
2021-12-0608:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-348517
2021-11-1616:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-331187
2021-11-1017:02 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-056273
2021-11-0909:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-323938
2021-09-0808:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-267306
2021-08-1116:12 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-043434
2021-08-0408:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-235775
2021-08-0208:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-232433
2021-06-2816:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-201933
2021-06-1716:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-193171
2021-05-1316:19 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-027570
2021-05-1208:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-158414
2021-05-0306:33 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-146514
2021-04-0508:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-105643
2021-03-3006:15 ET10-KAnnual reportPeriod 2020-12-310001564590-21-016297
2021-03-2508:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-093499
2021-02-1107:00 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-037280
2021-02-0106:43 ETS-1/ARegistration statement, amended0001193125-21-023615
2021-01-1516:02 ETS-1Registration statement0001193125-21-010054

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:01 ET. Listed shows no prices and gives no investment advice.